Results
1683
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1,683 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
6176 | NT$198.00 | 1.5% | 35.2% | NT$92.1b | NT$194.00 | PE15.8x | E-8.0% | 5.1% | Semiconductors | ||
2880 | NT$27.90 | -0.2% | 29.0% | NT$378.9b | NT$25.80 | PB1.8x | E0.4% | 4.3% | Banks | ||
2374 | NT$63.30 | 0.6% | 146.3% | NT$17.9b | n/a | PE38.4x | n/a | 1.4% | Consumer Durables | ||
5880 | NT$24.60 | 0.2% | -0.7% | NT$370.7b | n/a | PB1.5x | n/a | 2.6% | Banks | ||
2301 | NT$112.00 | 0.9% | 4.2% | NT$256.5b | NT$114.71 | PE20.9x | E17.3% | 4.0% | Tech | ||
8046 | NT$142.00 | -1.4% | -32.5% | NT$92.7b | NT$130.36 | PE105.7x | E89.8% | 3.9% | Tech | ||
6534 | NT$84.30 | 3.4% | -9.5% | NT$8.5b | n/a | PE22.7x | n/a | 4.3% | Materials | ||
3015 | NT$68.60 | 2.5% | 26.6% | NT$12.9b | n/a | PE32.6x | n/a | 4.7% | Capital Goods | ||
5533 | NT$19.85 | 0.8% | -14.1% | NT$5.7b | n/a | PE13.5x | n/a | 6.0% | Real Estate Management and Development | ||
2892 | NT$27.85 | 0.7% | 6.6% | NT$385.8b | NT$27.28 | PB1.5x | E-1.4% | 3.0% | Banks | ||
6405 | NT$29.95 | -8.0% | 17.2% | NT$2.0b | n/a | PS12.6x | n/a | 0.3% | Semiconductors | ||
3679 | NT$158.50 | 0.3% | 32.6% | NT$9.7b | n/a | PE17.2x | n/a | 4.7% | Capital Goods | ||
1519 | NT$624.00 | 10.1% | 30.0% | NT$183.5b | NT$805.67 | PE46.7x | E32.7% | 0.9% | Capital Goods | ||
1477 | NT$375.50 | 5.0% | 2.7% | NT$94.0b | NT$386.23 | PE22.8x | E8.8% | 3.7% | Consumer Durables | ||
3665 | NT$630.00 | -7.6% | 161.4% | NT$116.3b | NT$711.64 | PE34.5x | E38.9% | 1.4% | Capital Goods | ||
5016 | NT$28.20 | 0.4% | 0.9% | NT$1.4b | n/a | PE17.6x | n/a | 2.5% | Materials | ||
3716 | NT$39.10 | -1.4% | n/a | NT$5.8b | n/a | PE15.6x | n/a | 0% | Pharmaceuticals & Biotech | ||
3379 | NT$73.30 | 13.6% | 387.0% | NT$2.7b | n/a | PE66.3x | n/a | 0.3% | Capital Goods | ||
4157 | NT$11.55 | -0.9% | -23.0% | NT$8.4b | n/a | PE48.3x | n/a | n/a | Pharmaceuticals & Biotech | ||
6597 | NT$149.50 | 7.6% | 184.8% | NT$4.0b | n/a | PE34.2x | n/a | 1.0% | Tech | ||
3624 | NT$40.50 | -1.9% | -24.4% | NT$4.8b | n/a | PE22.2x | n/a | 3.0% | Tech | ||
5202 | NT$26.05 | -9.2% | 15.3% | NT$2.4b | n/a | PE6.9x | n/a | 2.7% | Software | ||
2063 | NT$37.40 | 5.8% | -31.1% | NT$1.9b | n/a | PE17.4x | n/a | 0% | Capital Goods | ||
1777 | NT$100.50 | 5.1% | 22.6% | NT$4.4b | n/a | PE13.7x | n/a | 3.5% | Pharmaceuticals & Biotech |